Artificial Intelligence in Drug Design—The Storm Before the Calm?

Allan M. Jordan

Research output: Contribution to journalArticlepeer-review

35 Downloads (Pure)

Abstract

Artificial intelligence in drug design in experiencing a wave of excitement not seen since the emergence of computational chemistry in the late 1980s and early 1990s. Apparently failing to learn the lessons of recent history, we are promised imminent and pervasive solutions to the ills of drug design and significant increases in productivity as we seek to deliver innovative new therapeutics. However, do significant issues remain to be answered before AI enters the day-to-day toolbox of the practicing medicinal chemist?
Original languageEnglish
JournalACS Medicinal Chemistry Letters
Early online date2 Nov 2018
DOIs
Publication statusPublished - 2018

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Fingerprint

Dive into the research topics of 'Artificial Intelligence in Drug Design—The Storm Before the Calm?'. Together they form a unique fingerprint.

Cite this